203 related articles for article (PubMed ID: 9870978)
1. Identification of the receptor subtype involved in the analgesic effect of neurotensin.
Dubuc I; Sarret P; Labbé-Jullié C; Botto JM; Honoré E; Bourdel E; Martinez J; Costentin J; Vincent JP; Kitabgi P; Mazella J
J Neurosci; 1999 Jan; 19(1):503-10. PubMed ID: 9870978
[TBL] [Abstract][Full Text] [Related]
2. The effects of deleting the mouse neurotensin receptor NTR1 on central and peripheral responses to neurotensin.
Pettibone DJ; Hess JF; Hey PJ; Jacobson MA; Leviten M; Lis EV; Mallorga PJ; Pascarella DM; Snyder MA; Williams JB; Zeng Z
J Pharmacol Exp Ther; 2002 Jan; 300(1):305-13. PubMed ID: 11752130
[TBL] [Abstract][Full Text] [Related]
3. Involvement of the neurotensin receptor 1 in the behavioral effects of two neurotensin agonists, NT-2 and NT69L: lack of hypothermic, antinociceptive and antipsychotic actions in receptor knockout mice.
Mechanic JA; Sutton JE; Berson AE; Wu X; Kwan J; Schreiber R; Pang Z; Button DC
Eur Neuropsychopharmacol; 2009 Jul; 19(7):466-75. PubMed ID: 19223157
[TBL] [Abstract][Full Text] [Related]
4. In vivo and in vitro structure-activity studies with peptide and pseudopeptide neurotensin analogs suggest the existence of distinct central neurotensin receptor subtypes.
Labbé-Jullié C; Dubuc I; Brouard A; Doulut S; Bourdel E; Pelaprat D; Mazella J; Martinez J; Rostène W; Costentin J
J Pharmacol Exp Ther; 1994 Jan; 268(1):328-36. PubMed ID: 8301574
[TBL] [Abstract][Full Text] [Related]
5. Targeted inactivation of the neurotensin type 1 receptor reveals its role in body temperature control and feeding behavior but not in analgesia.
Remaury A; Vita N; Gendreau S; Jung M; Arnone M; Poncelet M; Culouscou JM; Le Fur G; Soubrié P; Caput D; Shire D; Kopf M; Ferrara P
Brain Res; 2002 Oct; 953(1-2):63-72. PubMed ID: 12384239
[TBL] [Abstract][Full Text] [Related]
6. Neurotensin receptor-1 and -3 complex modulates the cellular signaling of neurotensin in the HT29 cell line.
Martin S; Navarro V; Vincent JP; Mazella J
Gastroenterology; 2002 Oct; 123(4):1135-43. PubMed ID: 12360476
[TBL] [Abstract][Full Text] [Related]
7. Neurotensin activation of the NTR1 on spinally-projecting serotonergic neurons in the rostral ventromedial medulla is antinociceptive.
Buhler AV; Choi J; Proudfit HK; Gebhart GF
Pain; 2005 Mar; 114(1-2):285-94. PubMed ID: 15733655
[TBL] [Abstract][Full Text] [Related]
8. Agonism, inverse agonism, and neutral antagonism at the constitutively active human neurotensin receptor 2.
Richard F; Barroso S; Martinez J; Labbé-Jullié C; Kitabgi P
Mol Pharmacol; 2001 Dec; 60(6):1392-8. PubMed ID: 11723247
[TBL] [Abstract][Full Text] [Related]
9. Interactions between NTS2 neurotensin and opioid receptors on two nociceptive responses assessed on the hot plate test in mice.
Bredeloux P; Costentin J; Dubuc I
Behav Brain Res; 2006 Dec; 175(2):399-407. PubMed ID: 17074405
[TBL] [Abstract][Full Text] [Related]
10. Neurotensin negatively modulates Akt activity in neurotensin receptor-1-transfected AV12 cells.
Liu F; Yang P; Baez M; Ni B
J Cell Biochem; 2004 Jun; 92(3):603-11. PubMed ID: 15156571
[TBL] [Abstract][Full Text] [Related]
11. Neurotensin enhances sperm capacitation and acrosome reaction in mice.
Hiradate Y; Inoue H; Kobayashi N; Shirakata Y; Suzuki Y; Gotoh A; Roh SG; Uchida T; Katoh K; Yoshida M; Sato E; Tanemura K
Biol Reprod; 2014 Aug; 91(2):53. PubMed ID: 25031361
[TBL] [Abstract][Full Text] [Related]
12. Neurotensin-produced antinociception in the rostral ventromedial medulla is partially mediated by spinal cord norepinephrine.
Buhler AV; Proudfit HK; Gebhart GF
Pain; 2008 Apr; 135(3):280-290. PubMed ID: 17664042
[TBL] [Abstract][Full Text] [Related]
13. Neuropeptide neurotensin stimulates intestinal wound healing following chronic intestinal inflammation.
Brun P; Mastrotto C; Beggiao E; Stefani A; Barzon L; Sturniolo GC; Palù G; Castagliuolo I
Am J Physiol Gastrointest Liver Physiol; 2005 Apr; 288(4):G621-9. PubMed ID: 15764810
[TBL] [Abstract][Full Text] [Related]
14. Molecular cloning and functional characterization of a type-I neurotensin receptor (NTR) and a novel NTR from the bullfrog brain.
Li JH; Sicard F; Salam MA; Baek M; LePrince J; Vaudry H; Kim K; Kwon HB; Seong JY
J Mol Endocrinol; 2005 Jun; 34(3):793-807. PubMed ID: 15956348
[TBL] [Abstract][Full Text] [Related]
15. Involvement of the neurotensin receptor subtype NTR3 in the growth effect of neurotensin on cancer cell lines.
Dal Farra C; Sarret P; Navarro V; Botto JM; Mazella J; Vincent JP
Int J Cancer; 2001 May; 92(4):503-9. PubMed ID: 11304684
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological effects of c(Lys-Lys-Pro-Tyr-Ile-Leu-Lys-Lys-Pro-Tyr-Ile-Leu) (JMV2012), a new analogue of neurotensin that crosses the blood-brain barrier.
Bredeloux P; Cavelier F; Dubuc I; Vivet B; Costentin J; Martinez J
J Med Chem; 2008 Mar; 51(6):1610-6. PubMed ID: 18321036
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of DOTA-chelated neurotensin analogs with spacer-enhanced biological performance for neurotensin-receptor-1-positive tumor targeting.
Jia Y; Shi W; Zhou Z; Wagh NK; Fan W; Brusnahan SK; Garrison JC
Nucl Med Biol; 2015 Nov; 42(11):816-23. PubMed ID: 26302836
[TBL] [Abstract][Full Text] [Related]
18. Involvement of NTS2 receptors in stress-induced analgesia.
Lafrance M; Roussy G; Belleville K; Maeno H; Beaudet N; Wada K; Sarret P
Neuroscience; 2010 Mar; 166(2):639-52. PubMed ID: 20035838
[TBL] [Abstract][Full Text] [Related]
19. Neurotensin and neurotensin receptors: characteristic, structure-activity relationship and pain modulation--a review.
Kleczkowska P; Lipkowski AW
Eur J Pharmacol; 2013 Sep; 716(1-3):54-60. PubMed ID: 23500196
[TBL] [Abstract][Full Text] [Related]
20. Emerging evidence for neurotensin receptor 1 antagonists as novel pharmaceutics in neurodegenerative disorders.
Ferraro L; Tomasini MC; Beggiato S; Guerrini R; Salvadori S; Fuxe K; Calzà L; Tanganelli S; Antonelli T
Mini Rev Med Chem; 2009 Oct; 9(12):1429-38. PubMed ID: 19929816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
